Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
Trial record 1 of 12 for:    raptiva for chronic moderate to severe plaque psoriasis
Previous Study | Return to List | Next Study

A Study to Evaluate Psoriasis Outcomes and Safety Events in Patients With Chronic Moderate to Severe Plaque Psoriasis (RESPONSE) (RESPONSE)

This study has been completed.
Information provided by:
Genentech, Inc. Identifier:
First received: November 17, 2004
Last updated: July 1, 2015
Last verified: March 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2009
  Estimated Primary Completion Date: No date given